Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1

Vanderbilt University32 enrolled

Overview

The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of hyperglycemia and hyperinsulinemia on endothelial function and fibrinolytic balance in Type 2 DM. Our hypothesis is that hyperglycemia, rather than hyperinsulinemia, is responsible for the dysregulation of fibrinolytic balance in diabetics.

This study will test the hypothesis that hyperglycemia will impair, while hyperinsulinemia will improve endothelial function and vascular fibrinolytic balance in type 2 DM. As discussed above, their roles in the increased prevalence of thrombotic events occurring in diabetics have not been defined. More recent data supports insulin as profibrinolytic and hyperglycemia to cause endothelial dysfunction. Conclusive studies are lacking in diabetic subjects. Furthermore, preliminary data from this lab indicates that in non-diabetic controls, hyperglycemia results in a prothrombotic state by increasing plasma PAI-1 and reducing tPA levels. The proposed protocol will study the separate and combined effects of hyperglycemia and hyperinsulinemia on endothelial function and fibrinolytic balance in Type 2 DM.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Type 2 Diabetes

Interventions

Hyperinsulinemic Hyperglycemic ClampOTHER

Glucose Clamp

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 16 ( 8 female/ 8 male) Type 2 diabetic patients age 18-60 yrs * 16 ( 8 female/ 8 male) Non-diabetic controls age and weight matched * Body mass index 25-52 kgm2 * Female volunteers of childbearing potential: negative HCG pregnancy test * Volunteers over 40 years old: normal baseline ECG * For those with type 2 diabetes: HBA1C 6.5-10% Exclusion Criteria: * Prior history of poor health: any current or prior disease condition that alters carbohydrate metabolism and prior cardiac events and/or evidence for cardiac disease * Uncontrolled hypertension * History of cerebrovascular incidents * Pregnancy * Subjects unable to give voluntary informed consent * Subjects with a recent medical illness * Subjects with known liver or kidney disease * Subjects on anticoagulant drugs, anemic, or with known bleeding diseases * Tobacco Use

Locations (1)

Vanderbilt University

Nashville, Tennessee, United States

Outcomes

Primary Outcomes

Endothelial function and fibrinolytic balance

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.